HPV Biomarkers in Oral and Blood‐Derived Body Fluids in Head and Neck Cancer Patients
Luisa Galati(European Institute of Oncology), Susanna Chiocca(European Institute of Oncology), Francesco Bandi(European Institute of Oncology), E Grosso(European Institute of Oncology), Jacopo Zocchi(European Institute of Oncology), Rita De Berardinis(European Institute of Oncology), Stefano Zorzi(European Institute of Oncology), Giacomo Pietrobon(European Institute of Oncology), Fausto Maffini(Istituti di Ricovero e Cura a Carattere Scientifico), Tarik Gheit(Centre international de recherche sur le cancer), Mohssen Ansarin(European Institute of Oncology), Giovanni Blandino(Istituti di Ricovero e Cura a Carattere Scientifico), Stefano Riccio(European Institute of Oncology), Marta Tagliabue(European Institute of Oncology), Massimo Tommasino(Centre international de recherche sur le cancer), Maria Lina Tornesello(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Laura Sichero(Instituto do Câncer do Estado de São Paulo), Gioacchino Giugliano(European Institute of Oncology), Francesco Chu(European Institute of Oncology), Luisa L. Villa(Universidade de São Paulo), Angelo Paradiso(Universidad de Oviedo), Sandrine McKay‐Chopin(Centre international de recherche sur le cancer), Giuseppe De Palma(Istituto Tumori Bari), Roberto Bruschini(European Institute of Oncology), Stefania Vecchio(Ospedale Policlinico San Martino), Chiara Mossinelli(European Institute of Oncology)
Cited by 5
Related Papers
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
Epidemiology of Acquisition and Clearance of Cervical Human Papillomavirus Infection in Women from a High‐Risk Area for Cervical Cancer
|The Journal of Infectious Diseases|1999|664
Epidemiologic Evidence and Human Papillomavirus Infection as a Necessary Cause of Cervical Cancer
|JNCI Journal of the National Cancer Institute|1999|538
Antimicrobial Peptides as Anticancer Agents: Functional Properties and Biological Activities
|Molecules|2020|375
TLR9 Expression and Function Is Abolished by the Cervical Cancer-Associated Human Papillomavirus Type 16
|The Journal of Immunology|2007|373